Quoin Pharmaceuticals Investor Relations Material

Quoin Pharmaceuticals Ltd is a U.S.-based specialty pharmaceutical company focused on the development and commercialization of therapeutic products for rare and orphan diseases. The company’s lead programs target conditions such as Netherton syndrome and other rare skin disorders. Quoin develops its drug candidates using proprietary delivery technologies and aims to address high unmet medical needs through both clinical research and strategic partnerships. The company is headquartered in Ashburn, Virginia, and its shares are listed on the NASDAQ.